Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ovarian carcinoma develops through multiple modes of chromosomal evolution.

Mattias Höglund1, David Gisselsson, Gunnar B Hansen

  • 1Department of Clinical Genetics, University Hospital, SE-221 85 Lund, Sweden. mattias.hoglund@klingen.lu.se

Cancer Research
|June 18, 2003
PubMed
Summary

Ovarian carcinoma evolves through distinct cytogenetic pathways and phases. Understanding these genomic imbalances aids in classifying tumor subtypes and predicting development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Journal of internal medicine·2026
Same author

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.

NPJ precision oncology·2026
Same author

Human Allele Frequency Distributions Contradict Current Narratives of Imminent Danger From Genetically Targeted Bioweapons.

Health security·2026
Same author

Stage-Independent Real-Time Subtype Classification and Comprehensive Biopsy Profiling of Urothelial Carcinomas by the Lund Taxonomy System.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Future-proofing medicine for a world of volatility, uncertainty, complexity, and ambiguity.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Re: Joshua J. Meeks. Urothelial Cancer: What Is the Role of Expression-based Subtypes to Guide Neoadjuvant Therapy in Muscle-invasive Bladder Cancer? Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.11.014.

European urology focus·2026

Area of Science:

  • Gynecologic Oncology
  • Cancer Genomics
  • Cytogenetics

Background:

  • Ovarian carcinoma is the deadliest gynecologic cancer, characterized by complex chromosomal abnormalities and aneuploidy.
  • Despite numerous published karyotypes, the evolutionary pathways of ovarian tumors remain poorly understood.

Purpose of the Study:

  • To identify frequent genomic imbalances in ovarian carcinoma.
  • To determine the order of chromosomal imbalance acquisition and define cytogenetic pathways and subtypes.

Main Methods:

  • Analysis of 387 ovarian carcinoma karyotypes.
  • Statistical assessment of genomic imbalances to establish temporal order and identify distinct evolutionary pathways.
  • Classification of tumors based on the presence or absence of key imbalances.

Related Experiment Videos

Main Results:

  • Identification of at least two distinct cytogenetic pathways: one involving +7, +8q, and +12, and another involving 6q- and 1q-.
  • Demonstration of three distinct phases of karyotypic evolution in ovarian carcinomas.
  • Phase II transition linked to increased chromosomal instability and breakage-fusion-bridge cycles, associated with the 6q-/1q- pathway.
  • Phase III transition characterized by triploidization, also linked to the 6q-/1q- pathway.

Conclusions:

  • Ovarian carcinoma development follows at least two major cytogenetic pathways and three evolutionary phases.
  • The 6q-/1q- pathway is associated with increased chromosomal instability and triploidization in later stages of tumor development.